Professor Chris Lord's group investigates the genetic basis of breast cancer as a means to understand and treat the disease.
Professor Chris Lord is Deputy Head of Division and the leader of the CRUK Gene Function Group, which applies concepts such as synthetic lethality and non-oncogene addiction to provide one route to identifying novel approaches to treating cancer.